Literature DB >> 28608390

Novel nomogram combining depth of invasion and size can accurately predict the risk for regional nodal metastases for appendiceal neuroendocrine tumors (A-NET).

Catalina Mosquera1, Timothy L Fitzgerald2, Haily Vora3, Marysia Grzybowski4.   

Abstract

INTRODUCTION: The need for regional lymphadenectomy for treating appendiceal neuroendocrine tumors (A-NET) is determined by the risk of nodal metastasis. Current guidelines for A-NET are solely based on tumor size. Methods Patients with A-NET from 1988 to 2012 were identified from the SEER registry. The depth of invasion was defined as limited to the lamina propria (LP), invading the muscularis propria (MP), and through the serosa (TS).
RESULTS: A total of 418 patients were included; the majority were female, white, and node-negative. On univariate and multivariable, the risk of nodal metastasis was associated with age, size, depth of invasion, and extent of surgery. The model predicted the likelihood of nodal metastasis, with an area under the curve of 0.89. On survival analysis, age and tumor size predicted the survival in A-NET. In a Cox regression model, they continued to predict survival. These data were utilized to create a nomogram to predict the risk of nodal metastases.
CONCLUSION: This nomogram, accurately predicts the risk of regional nodal metastases in A-NET. In addition to providing valuable information on risk for regional nodal metastases, the depth of invasion is also predictive of survival for A-NET.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  appendix; depth of invasion; lymphadenectomy; neuroendocrine tumors; size

Mesh:

Year:  2017        PMID: 28608390     DOI: 10.1002/jso.24714

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  Practice Patterns and Guideline Non-Adherence in Surgical Management of Appendiceal Carcinoid Tumors.

Authors:  Danielle R Heller; Raymond A Jean; Jiajun Luo; Vadim Kurbatov; Gabriella Grisotti; Daniel Jacobs; Alexander S Chiu; Yawei Zhang; Sajid A Khan
Journal:  J Am Coll Surg       Date:  2019-03-19       Impact factor: 6.113

2.  Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group.

Authors:  Katiuscha Merath; Fabio Bagante; Eliza W Beal; Alexandra G Lopez-Aguiar; George Poultsides; Eleftherios Makris; Flavio Rocha; Zaheer Kanji; Sharon Weber; Alexander Fisher; Ryan Fields; Bradley A Krasnick; Kamran Idrees; Paula M Smith; Cliff Cho; Megan Beems; Carl R Schmidt; Mary Dillhoff; Shishir K Maithel; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2018-02-15       Impact factor: 3.454

Review 3.  Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy.

Authors:  José Luis Muñoz de Nova; Jorge Hernando; Miguel Sampedro Núñez; Greissy Tibisay Vázquez Benítez; Eva María Triviño Ibáñez; María Isabel Del Olmo García; Jorge Barriuso; Jaume Capdevila; Elena Martín-Pérez
Journal:  World J Gastroenterol       Date:  2022-04-07       Impact factor: 5.374

Review 4.  Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Andrew Canakis; Linda S Lee
Journal:  World J Gastrointest Endosc       Date:  2022-05-16

5.  A novel and validated nomogram to predict overall survival for gastric neuroendocrine neoplasms.

Authors:  Sheng Zhang; Yi Xin Tong; Xin Hua Zhang; Yu Jie Zhang; Xiang Shang Xu; Ai Tang Xiao; Teng Fei Chao; Jian Ping Gong
Journal:  J Cancer       Date:  2019-10-15       Impact factor: 4.207

6.  Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.

Authors:  Zihan Xu; Li Wang; Shuang Dai; Mingjing Chen; Feng Li; Jianguo Sun; Feng Luo
Journal:  JAMA Netw Open       Date:  2021-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.